Skip to main navigation Skip to search Skip to main content

A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer

  • Gemelli Molise

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)E400-E403
JournalAmerican Journal of Hematology
Volume97
DOIs
Publication statusPublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Female
  • Humans
  • Leukemia, Myeloid, Acute
  • Mutation
  • Myelodysplastic Syndromes
  • Ovarian Neoplasms
  • Poly(ADP-ribose) Polymerase Inhibitors

Cite this